AbstractPurified human respiratory syncytial virus (HRSV) P phosphoprotein from transfected HEp-2 cells is able to oligomerize forming tetramers. The bulk of constitutive P protein phosphorylation (99.8%) (serine residues 116, 117, 119, 232 and 237) can be removed without affecting protein oligomerization. However, dephosphorylated P protein, produced in bacteria, is unable to oligomerize. This difference can be explained by a transient P protein phosphorylation, detected in HEp-2 cells, that could be essential for P protein oligomerization
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
AbstractPurified human respiratory syncytial virus (HRSV) P phosphoprotein from transfected HEp-2 ce...
Human Respiratory Syncytial Virus P protein plus the viral RNA, N and L viral proteins, constitute t...
International audienceRabies virus (PV strain) phosphoprotein (P) was expressed in bacteria. This re...
AbstractThe phosphoprotein P of human respiratory syncytial virus (RSV) was expressed in eukaryotic ...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
AbstractThe human respiratory syncytial virus (HRSV) structural P protein, phosphorylated at serine ...
The bulk of the phosphorylation of human respiratory syncytial virus phosphoprotein is not essential...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
AbstractPurified human respiratory syncytial virus (HRSV) P phosphoprotein from transfected HEp-2 ce...
Human Respiratory Syncytial Virus P protein plus the viral RNA, N and L viral proteins, constitute t...
International audienceRabies virus (PV strain) phosphoprotein (P) was expressed in bacteria. This re...
AbstractThe phosphoprotein P of human respiratory syncytial virus (RSV) was expressed in eukaryotic ...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
International audienceIt was shown previously that the matrix (M), phosphoprotein (P), and fusion (F...
AbstractThe human respiratory syncytial virus (HRSV) structural P protein, phosphorylated at serine ...
The bulk of the phosphorylation of human respiratory syncytial virus phosphoprotein is not essential...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...
International audiencePeptide-based inhibitors hold promising potential in the development of antivi...